Back to Search
Start Over
Low vitamin B 12 increases risk of gastric cancer: A prospective study of one-carbon metabolism nutrients and risk of upper gastrointestinal tract cancer.
- Source :
-
International journal of cancer [Int J Cancer] 2017 Sep 15; Vol. 141 (6), pp. 1120-1129. Date of Electronic Publication: 2017 Jun 21. - Publication Year :
- 2017
-
Abstract
- Previous studies have found associations between one-carbon metabolism nutrients and risk of several cancers, but little is known regarding upper gastrointestinal tract (UGI) cancer. We analyzed prediagnostic serum concentrations of several one-carbon metabolism nutrients (vitamin B12, folate, vitamin B6, riboflavin and homocysteine) in a nested case-control study within the Alpha-Tocopherol, Beta-Carotene Cancer Prevention (ATBC) Study of male smokers, which was undertaken in Finland between 1985 and 1988. We conducted a nested case-control study including 127 noncardia gastric adenocarcinoma (NCGA), 41 esophagogastric junctional adenocarcinoma and 60 esophageal squamous cell carcinoma incident cases identified within ATBC. Controls were matched to cases on age, date of serum collection and follow-up time. One-carbon nutrient concentrations were measured in fasting serum samples collected at baseline (up to 17 years prior to cancer diagnosis). Odds ratios and 95% confidence intervals (CI) were calculated using conditional logistic regression. Lower prediagnostic vitamin B12 concentrations at baseline were associated with a 5.8-fold increased risk of NCGA (95% CI = 2.7-12.6 for lowest compared to highest quartile, p-trend <0.001). This association remained in participants who developed cancer more than 10 years after blood collection, and after restricting the analysis to participants with clinically normal serum vitamin B12 (>300 pmol/L). In contrast, pepsinogen I, a known serologic marker of gastric atrophy, was not associated with NCGA in this population. As vitamin B12 absorption requires intact gastric mucosa to produce acid and intrinsic factor, our findings suggest vitamin B12 as a possible serologic marker for the atrophic gastritis that precedes NCGA, one more strongly associated with subsequent NCGA than pepsinogen.<br /> (Published 2017. This article is a US Government work and, as such, is in the public domain of the United States of America.)
- Subjects :
- Aged
Carcinoma, Squamous Cell epidemiology
Carcinoma, Squamous Cell pathology
Case-Control Studies
Dietary Supplements
Esophageal Neoplasms epidemiology
Esophageal Neoplasms pathology
Esophageal Squamous Cell Carcinoma
Finland epidemiology
Folic Acid blood
Homocysteine blood
Humans
Male
Middle Aged
Prospective Studies
Riboflavin blood
Stomach Neoplasms epidemiology
Stomach Neoplasms pathology
Vitamin B 12 Deficiency pathology
alpha-Tocopherol administration & dosage
beta Carotene administration & dosage
Carcinoma, Squamous Cell blood
Esophageal Neoplasms blood
Stomach Neoplasms blood
Vitamin B 12 blood
Vitamin B 12 Deficiency blood
Subjects
Details
- Language :
- English
- ISSN :
- 1097-0215
- Volume :
- 141
- Issue :
- 6
- Database :
- MEDLINE
- Journal :
- International journal of cancer
- Publication Type :
- Academic Journal
- Accession number :
- 28568053
- Full Text :
- https://doi.org/10.1002/ijc.30809